TAMSULOSIN HYDROCHLORIDE | N020579 | SANOFI AVENTIS US LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Amendment to Suitability Petition from Rising Pharma Holdings, Inc. FDA-2026-P-3630 · 6 docket documents Rising Pharma Holdings, Inc. submitted an amendment to its suitability petition FDA-2026-P-3630 on April 28, 2026, providing the reference listed drug product labeling for FLOMAX and proposed product labeling for Tamsulosin Hydrochloride Capsules, USP 0.8 mg in response to the FDA's April 20, 2026 i | Suitability | 2026-04-28 | Open | Rising Pharma Holdings, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.